• Anggra Permana Putra Department of Obstetrics and Gynecology, Faculty of Medicine, Andalas University/ Dr. M. Djamil General Hospital, Padang
  • Bobby Indra Utama Subdivision of Urogynecology and Reconstructive Surgery, Department of Obstetrics and Gynecology, Faculty of Medicine, Andalas University/ Dr. M. Djamil Hospital Padang
  • Husna Yetti Department of Public Health – Community Medicine, Faculty of Medicine, Andalas University



Metabolic syndrome, OAB


Overactive Bladder (OAB) is a chronic medical condition that has a negative impact on an individual's health and quality of life. Cardiovascular problems are considered to be one of the risks associated with OAB where one of the higher cardiovascular parameters is metabolik syndrome. Aim to determine the relationship between  metabolik syndrome and Overactive Bladder in female patients at Dr. M. Djamil Hospital Padang. Quantitative research with a case control design using a questionnaire according to the Overactive Bladder Symptom Score (OABSS) and examination based on metabolik syndrome symptoms. The research was conducted at Dr. M. Djamil Hospital Padang in November 2022 to September 2023. There were 60 respondents who were divided into the OAB (28/60) and no-OAB group (32/60). Most respondents were aged 50-59 years (45,0%), graduated from high school (53.3%), worked as housewives (76.7%) and had diabetes mellitus (78,3%). In this study it was also found that 48,3% of respondents suffered from hypertension and 45.0% suffered from obesity. A total of 46.7% of respondents experienced OAB symptoms with a higher percentage of OAB found in the metabolik syndrome group (76,7%) than no-metabolik syndrome group (16.7%). Bivariate analysis found a relationship between metabolik syndrome and overactive bladder symptoms (p = 0.000) with metabolik syndrome affected the incidence of overactive bladder by 16.4 times (OR 16.42, (CI 95% 4.56-59.07). There is a relationship between metabolik syndrome and the incidence of OAB.

Author Biography

Husna Yetti, Department of Public Health – Community Medicine, Faculty of Medicine, Andalas University



Leron, E., Weintraub, A. Y., Mastrolia, S. A. & Schwarzman, P. Overactive Bladder Syndrome: Evaluation and Management. Curr. Urol. 11, 117–125 (2018).

Pratt, T. S. & Suskind, A. M. Management of overactive bladder in older women. Curr. Urol. Rep. 19, 1–10 (2018).

Reynolds, W. & JA, C. Overactive Bladder.

Harding, C. K. et al. EAU guidelines on management of non-neurogenic female lower urinary tract symptoms (LUTS). Eur. Assoc. Urol. Guidel. (2021).

Raju, R. & Linder, B. Evaluation and Treatment of Overactive Bladder in Women. Mayo Clin. 95, 370–378 (2020).

Ubee, S. S., Manikandan, R. & Singh, G. Medical management of overactive bladder. Indian J. Urol. 26, 270–278 (2010).

Scarneciu, I. et al. Overactive bladder: A review and update. Exp. Ther. Med. 22, 1–8 (2021).

Zacche, M., Giarenis, I., Thiagamoorthy, G., D, R. & Cardozo, L. Is There an Association between Aspects of the Metabolik Syndrome and Overactive Bladder? A Prospective Cohort Study in Women with Urinary Tract Symptoms. Eur. J. Obstet. Gynecol. Reprod. Biol. 217, 1–5 (2017).

Dagdeviren, H. & Cengiz, H. Association between metabolik syndrome and serum nerve growth factor levels in women with overactive bladder. Gynecol. Obstet. Invest. 83, 140–144 (2018).

Schimit, G. T. F. et al. Is there a link between carotid atherosclerosis and idiopathic overactive bladder among women with metabolik syndrome? Res. Reports Urol. 12, 43 (2020).

Bunn, F. et al. Is there a link between overactive bladder and the metabolik syndrome in women? A systematic review of observational studies. Int. J. Clin. Pract. 69, 199–217 (2015).

Akin, Y. et al. Relationship between neck circumference and overactive bladder in women with metabolik syndrome: a preliminary study. Wien. Klin. Wochenschr. 128, 581–586 (2016).

Omran, A. et al. Metabolik syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors. Ther. Adv. Endocrinol. Metab. 12, 1–29 (2021).

Baytaroglu, C. & Sevgili, E. Association of Metabolik Syndrome Components and Overactive Bladder in Women. Cureus 13, (2021).

Uzun, H., Yilmaz, A., Kemik, A., Zorba, O. U. & Kalkan, M. Association of insulin resistance with overactive bladder in female patients. Int. Neurourol. J. 16, 181–186 (2012).

Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71-76. Published 2016 Jun 6. doi:10.2147/RRU.S102441.

Gouveia ÉR, Gouveia BR, Marques A, et al. Predictors of Metabolik Syndrome in Adults and Older Adults from Amazonas, Brazil. Int J Environ Res Public Health. 2021;18(3):1303. Published 2021 Feb 1. doi:10.3390/ijerph18031303.

İrer B, Şen V, Bozkurt O, Demir Ö, Esen A. Prevalence and Possible Risk Factors of Overactive Bladder Symptoms in Women Living in the City of İzmir. J Urol Surg 2018;5:180-187.

Stephens CR, Easton JF, Robles-Cabrera A, et al. The Impact of Education and Age on Metabolik Disorders. Front Public Health. 2020;8:180. Published 2020 May 20. doi:10.3389/fpubh.2020.00180

Chae J, Yoo EH, Jeong Y, Pyeon S, Kim D. Risk factors and factors affecting the severity of overactive bladder symptoms in Korean women who use public health centers. Obstet Gynecol Sci. 2018;61(3):404-412. doi:10.5468/ogs.2018.61.3.404

Saratlija Novakovic Z, Tesija RA, Puljak L. Association between metabolik syndrome and overactive bladder: a case-control study. Scand J Urol. 2017;51(6):470-473. doi:10.1080/21681805.2017.1354912

Nsiah K, Shang VO, Boateng KA, Mensah FO. Prevalence of metabolik syndrome in type 2 diabetes mellitus patients. Int J Appl Basic Med Res. 2015;5(2):133-138. doi:10.4103/2229-516X.157170

Rosa D, Villa G, Bonetti L, Togni S, Destrebecq A, Montanari E, dkk. The relationship between overactive bladder, metabolik syndrome and shift work: A literature review. International Journal of Urological Nursing. 2021; 16(2):73-9

Zuo, S. W., English, K., Agalliu, I., Leegant, A. & Abraham, N. Racial and ethnic differences in urodynamic parameters in women with overactive bladder symptoms. Female Pelvic Med. Reconstr. Surg. 26, 141–145 (2020).

Aydın A., Tuzcu M. S., Elçi Atılgan A., Sönmez M. G. , Özcan S. , Göger Y. E. , Balasar M. Effect of Metabolik Syndrome-Related Parameters on Overactive Bladder. The New Journal of Urology. 2020; 15(3): 200-206.

Hsu, L.-N., Hu, J.-C., Chen, P.-Y., Lee, W.-C. & Chuang, Y.-C. Metabolik Syndrome and Overactive Bladder Syndrome May Share Common Pathophysiologies. Biomedicines 10, 1957 (2022).